首页> 外文OA文献 >The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats

【2h】

The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats

机译：过氧化物酶体增殖物激活受体（PPAR）α激动剂非诺贝特可维持卵巢切除大鼠的骨量，而PPARγ激动剂吡格列酮可加剧骨丢失。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Astrid K Stunes; Irene Westbroek; Björn I Gustafsson; Reidar Fossmark; Jan H Waarsing; Erik F Eriksen; Christiane Petzold; Janne E Reseland; Unni Syversen;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats [J] . Astrid K Stunes, Irene Westbroek, Bj?rn I Gustafsson, BMC Endocrine Disorders . 2011,第1期

机译：过氧化物酶体增殖物激活受体（PPAR）α激动剂非诺贝特维持骨量，而PPARγ激动剂吡格列酮在去卵巢大鼠中夸大了骨质流失
2. Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone [J] . Unni Syversen, Astrid K Stunes, Bj?rn I Gustafsson, BMC Endocrine Disorders . 2009,第1期

机译：过氧化物酶体增殖物激活受体（PPAR）α激动剂非诺贝特和PPARγ激动剂吡格列酮对骨骼的不同作用
3. Effects of the Peroxisome Proliferator-Activated Receptor (PPAR)-delta Agonist GW501516 on Bone and Muscle in Ovariectomized Rats [J] . Mosti M. P., Stunes A. K., Ericsson M., Endocrinology . 2014,第6期

机译：过氧化物体增殖物激活受体（PPAR）-Delta激动剂GW501515对卵巢大鼠骨骼和肌肉的影响
4. New In Vitro Strategy of Astrocytoma (Astrocytes-like) Cells Treated with Pioglitazone (PPAR gamma agonist) Offers Neuroprotection Against Nanoparticles-lnduced Cytotoxicity [C] . Yin Yin W. Wong, Ashvin Jaiswal, Vikas V. Dukhande, NSTI nanotechnology conference and expo;Nanotech conference expo;NSTI-Nanotech 2011;TechConnect world annual conference expo . 2011

机译：吡格列酮（PPARγ激动剂）治疗的星形细胞瘤（星形胶质细胞）细胞新的体外策略提供了针对纳米颗粒诱导的细胞毒性的神经保护作用
5. Peroxisome Proliferator-activated Receptor-γ (PPARγ) Agonists: Potential Novel Treatment for HIV-1 Associated Brain Inflammation [D] . Omeragic, Amila . 2020

机译：过氧化物体增殖物激活受体-γ（PPARγ）激动剂：对HIV-1相关脑炎症的潜在新待遇
6. The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass while the PPAR gamma agonist pioglitazone exaggerates bone loss in ovariectomized rats [O] . Astrid K Stunes, Irene Westbroek, Björn I Gustafsson, 2011

机译：过氧化物酶体增殖物激活受体（PPAR）α激动剂非诺贝特可维持卵巢切除大鼠的骨量而PPARγ激动剂吡格列酮可加剧骨丢失。
7. The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats [O] . Stunes A.K. (Astrid), Westbroek I., Gustafsson B.I. (Björn), 2011

机译：过氧化物酶体增殖物激活受体（PPAR）α激动剂非诺贝特可维持卵巢切除大鼠的骨量，而PPARγ激动剂吡格列酮可加剧骨丢失。

The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats

著录项

相似文献

相关主题

期刊订阅